You have 9 free searches left this month | for more free features.

Multiple myeloma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma Trial in Boston (Elranatamab)

Not yet recruiting
  • Refractory Multiple Myeloma
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 17, 2023

Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • 18F-fluciclovine injection
  • 18F-FDG PET/CT
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 31, 2023

Clinical Pathways for Newly Diagnosed Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Multiple Myeloma Without Mention of Remission
  • Multiple Myeloma Pathway
  • +2 more
  • (no location specified)
Nov 27, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Oct 30, 2023

Multiple Myeloma Trial in Tucson (Immediate yoga intervention, Delayed yoga intervention)

Not yet recruiting
  • Multiple Myeloma
  • Immediate yoga intervention
  • Delayed yoga intervention
  • Tucson, Arizona
    University of Arizona Cancer Center
Sep 27, 2023

Multiple Myeloma Trial (AZD0305)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 24, 2023

Multiple Myeloma Trial (Teclistamab, Tocilizumab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 24, 2023

Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting
  • Smoldering Multiple Myeloma (SMM)
  • (no location specified)
Jul 13, 2023

Multiple Myeloma Trial (CM313 injection)

Not yet recruiting
  • Multiple Myeloma
  • CM313 injection
  • (no location specified)
Nov 6, 2023

Multiple Myeloma Trial in Boston (THRIVE-M)

Not yet recruiting
  • Multiple Myeloma
  • THRIVE-M
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 2, 2023

Multiple Myeloma Prognostic Indices

Recruiting
  • Multiple Myeloma
  • Hematologic Diseases
  • blood viscosity , albumin / fibrinogen ratio and red cell distribution
  • Assiut, Egypt
    Assiut University hospital
Oct 17, 2023

Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Smoldering Multiple Myeloma (SMM)
  • (no location specified)
Nov 17, 2023

Multiple Myeloma Trial in Zwolle (e-coach multipel myeloma (MM))

Recruiting
  • Multiple Myeloma
  • e-coach multipel myeloma (MM)
  • Zwolle, Overijssel, Netherlands
    Isala Klinieken
Jul 26, 2023

Multiple Myeloma, Smoldering Multiple Myeloma Trial in Oslo (TG01)

Not yet recruiting
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • TG01
  • Oslo, Norway
    Oslo Myeloma Center
May 2, 2023

Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • Köln, Germany
    Local Institution - 0017
Dec 4, 2023

Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)

Recruiting
  • Multiple Myeloma
  • Total Marrow irradiation,TMI
  • Autologous hematopoietic stem cell transplantation
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 24, 2023

Multiple Myeloma Trial in Montréal (Elranatamab)

Not yet recruiting
  • Multiple Myeloma
  • Montréal, Quebec, Canada
    McGill University Health Centre
Sep 21, 2023

Examination of Trends in Multiple Myeloma Trial Patient

Not yet recruiting
  • Multiple Myeloma
    • (no location specified)
    May 19, 2023

    Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Cleveland (Multiple

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Multiple Myeloma M-Protein Analysis
    • Multiple Myeloma Knowledge Questionnaires
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Apr 26, 2023

    Multiple Myeloma in Relapse Trial in Shenzhen (BCMA/GPRC5D double CAR-T)

    Recruiting
    • Multiple Myeloma in Relapse
    • BCMA/GPRC5D double CAR-T
    • Shenzhen, Guangdong, China
      Shenzhen Qianhai Shekou Free Trade Zone Hospital
    Sep 28, 2023

    Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Oct 25, 2023

    Multiple Myeloma Trial in Wollongong (IBI3003)

    Not yet recruiting
    • Multiple Myeloma
    • Wollongong, New South Wales, Australia
      Wollongong Private Hospital
    Oct 18, 2023

    Relapsed/Refractory Multiple Myeloma Trial in Suzhou (ICI201)

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Suzhou, Jiangsu, China
      First Affiliated Hospital, Soochow University
    Jul 31, 2023

    New Echocardiographic Indicators in Treatment of Primary

    Not yet recruiting
    • Multiple Myeloma
    • Chemotherapy and/or autologous hematopoietic stem cell transplantation
    • (no location specified)
    Sep 18, 2023

    Multiple Myeloma, Multiple Myeloma in Relapse Trial (Belantamab mafodotin, Venetoclax)

    Not yet recruiting
    • Multiple Myeloma
    • Multiple Myeloma in Relapse
    • Belantamab mafodotin, Venetoclax
    • (no location specified)
    May 10, 2023